Panrazol (Pantoprazole Sodium)

Pantoprazole, the active ingredient in Panrazol, is a proton pump inhibitor presented as a strength/form for gastroenteral use. It treats acid‑related disorders such as GERD, erosive esophagitis, peptic ulcer disease and Zollinger‑Ellison syndrome in adults.

GNH USA supplies Panrazol as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Panrazol is a proton pump inhibitor used in the management of acid‑related gastrointestinal conditions. - Gastro‑esophageal reflux disease (GERD): reduces reflux symptoms and promotes healing of the esophageal lining. - Erosive esophagitis: accelerates healing of erosive lesions in the esophagus. - Peptic ulcer disease: supports ulcer healing and helps prevent recurrence. - Zolligan‑Ellison syndrome: controls gastric acid hypersecretion associated with gastrin‑producing tumors.

Pantrazol may cause adverse reactions, most of which are mild and transient.

Common Side Effects: - Headache - Diarrhea - Nausea - Abdominal pain - Flatulence - Constipation

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis) - Clostridioides difficile‑associated colitis - Low magnesium levels (hypomagnesemia) - Liver enzyme abnormalities - Fracture risk increased - Acute interstitial nephritis

When using Panitz...

The